NCT00337831

Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 17 (actual)
• Sponsor: University Hospital, Ghent · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Patients will be treated with hemodiafiltration (HDF) in postdilution mode, as a control therapy, during 9 weeks. During week 5 the 1st intervention treatment, predilution hemofiltration (HF) or predilution HDF, will be performed as a midweek session. After 4 additional weeks of control therapy the other intervention treatment will be performed. Samples will be taken during week 4, 5 and 9: from inlet blood flow (0, 30, 60, 120 and 240 min), from outlet blood flow and dialysate outflow (30, 60, 120 and 240 min).

Conditions

• Chronic Renal Failure

Interventions

Type	Name	Description
PROCEDURE	Performance of predilution hemofiltration, predilution hemodiafiltration or postdilution hemodiafiltration	Performance of predilution hemofiltration, predilution hemodiafiltration or postdilution hemodiafiltration is followed.

Timeline

• Start date: 2006-05-01
• Primary completion: 2007-02-01
• Completion: 2007-05-01
• First posted: 2006-06-16
• Last updated: 2011-06-30

Locations

1 site across 1 country: Belgium